HIV Care and Treatment: Benefits of Electronic Medical Records Phyllis Kanki 1, Seema Meloni 1,Beth Chaplin 1, Bolanle Banigbe 2, Prosper Okonkwo 2 1 Harvard.

Slides:



Advertisements
Similar presentations
Antiretroviral Therapy Standard Core Indicators. Emergency Plan for AIDS Relief 2 million people reached with ART 7 million new infects prevented 10 million.
Advertisements

Follow-up after training and supportive supervision The IMAI District Coordinator Course.
Part A/Module A1/Session 4 Part A: Module A1 Session 4 Comprehensive Care for People Living with HIV/AIDS (PLHA)
A Training Needs Analysis of Health Workforce Competencies in HIV Care and Treatment Services in Rwanda (L305) Presented by: Dr. Peter Memiah Presented.
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
Designing a National PMTCT Impact Evaluation for Option B+ in Malawi Dr. Beth A. Tippett Barr, CDC-Malawi AIDS Turning the Tide Together.
Integrated Monitoring and Evaluation of HIV Programs in Malawi Dr Andreas Jahn 1,2 1 Dept. for HIV and AIDS, MOH, Malawi 2 I-TECH Malawi.
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
The Laboratory’s Key Role in Scale-Up and Sustainability Seema Meloni, Ph.D., M.P.H. Harvard School of Public Health AIDS 2012: Turning the Tide Together.
Costs and Outcomes of AIDS Treatment Delivery Models Sydney Rosen ab, Lawrence Long b, Ian Sanne bc a Center for International Health and Development,
Stable Outcomes and Costs in South African Patients’ Second Year on Antiretroviral Treatment Lawrence Long, Health Economics Research Office, Wits Health.
AIDS International Training & Research Program (AITRP) Research Workshop Abuja, Nigeria Rockview Hotel Royale (Ameachi Hall) May 6, 2010 FINAL Agenda Sponsored.
ART drug resistance mutations Implications for TDF use Phyllis Kanki and Beth Chaplin Harvard PEPFAR Harvard School of Public Health.
Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.
Presentation Title Presenter(s) Centers for Disease Control and Prevention AIDS Turning the Tide Together.
ABSTRACT Background: A retrospective medical record review was conducted to evaluate implementation of the Public Health Service recommendations for laboratory.
Assessing & Improving Quality of Care Newly Developed Quality of Care Tools President’s Emergency Plan for AIDS Relief Track 1.0 ART Program Meeting Seema.
Botswana National Program: Nurses Dispensing ARVs Tendani Gaolathe M.D Director Botswana-Harvard Partnership /PEPFAR Master Trainer Program.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
AIDS Prevention Initiative Nigeria Monitoring and Evaluation in the Transition Toyin Jolayemi – APIN Ltd Seema Meloni - Harvard.
Phyllis Kanki Harvard School of Public Health VIIIth Annual Track 1.0 ART Meeting August 2010.
Quality Assessment and Improvement Harvard – PEPFAR Tanzania, Nigeria and Botswana.
Use of routinely collected service delivery and M&E indicator data for timely feedback Denis Nash, PhD, MPH Associate Professor of Epidemiology Director,
Quality of Care at a Multi-site PEPFAR-funded ART Program: From Measuring to Improvement.
Integrated Health Programs for Women and Children: Lessons from the Field Dr. Ambrose Misore Project Director, APHIA II Western, PATH’s Kenya Country Program.
Satellite Roll Out and Lab Capacity Building in Harvard PEPFAR Dr. Toyin Jolayemi APIN/Harvard PEPFAR, Nigeria.
HARVARD-BHP ASSESSMENT J OSE “R AFI ” M ORALES, MD, FACOG C HIEF M EDICAL O FFICER Clinical Assessment for Systems Strengthening (ClASS) HRSA, HIV/AIDS.
Experience with Tb diagnostics and Scale up of services Botswana, Nigeria, and Tanzania Ernest Ekong, MD,MPH National Clinical Coordinator Harvard PEPFAR.
Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.
Orientation on HIV care and ART Recording and Reporting System.
EARLY CHILDHOOD OUTCOMES AT THE BOTSWANA- BAYLOR CHILDREN’S CLINICAL CENTRE OF EXCELLENCE: A REPORT TO THE WHO TECHNICAL REFERENCE GROUP ON PEDIATRIC CARE.
1 Monitoring The Patient on ARV Treatment HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
Scaling up HIV Paediatric care Harvard – PEPFAR Program Chalamilla Guerino
Psychosocial support model for community - based ART initiatives: Zimbabwe experience. Sostain Moyo G.Kadzirange, L. S. Zijenah, T. Kufa. L. Gwanzura,
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
ZIMBABWE AIDS CARE FOUNDATION NEWLANDS CLINIC Virological Outcomes in Adult Patients on Second Line ART, at Newlands Clinic Dr S. Bote.
Data dissemination meeting February 28, 2007 ICAP New York.
Use of Routine Feedback Reports to Site and District Staff in Cote d’Ivoire Hermann Brou Annual Meeting, M&E satellite meeting Johannesburg, July 28, 2010.
Potential Utility of Tipranavir in Current Clinical Practice Daniel R. Kuritzkes, MD Director of AIDS Research Brigham and Woman’s Hospital Division of.
Dr Rochelle Adams ACC Project Manager On behalf of the ACC team AWACC November 2015 Health systems Strengthening for Success and Sustainability.
Sub module 1 Introduction to HIV care and ART recording and reporting system.
Mövenpick Royal Palm Hotel Dar es Salaam, Tanzania August 4-6, 2009 The 7th Annual Track 1.0 ART Program Meeting.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
HIVQUAL – ARV Management October 17, 2003 Saneese Stephen, RPA Kings County Hospital Center Center for H.O.P.E.
Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.
EMTCT in Europe. MTCT rates, UK and Ireland, CROI 2007 Poster 761, Townsend et al diagnosed women, Low rates of MTCT from diagnosed.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Accumulation of Protease Mutations Among Patients on Non-Suppressive 2 nd -Line ART in Nigeria H. Rawizza, B. Chaplin, S. Meloni, P. Okonkwo, P. Kanki.
ICAP Quarterly Master Slide Set July-September 2007.
HHS/CDC Track 1.0 Transition in Rwanda Dr Ida Kankindi, Rwanda Ministry of Health Dr Felix Kayigamba, CDC-Rwanda August
1 Uses of Data from the WHO HIV Drug Resistance Strategy: 1. Monitoring of HIVDR emerging in treated groups in sentinel ART clinics HIV Drug Resistance.
Clinical Documentation Pharmacy Department Dale Tucker, RPh, BCPS Harper University Hospital Hutzel Women’s Hospital Karmanos Cancer Hospital Rehabilitation.
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
Harvard PEPFAR BotswanaNigeriaTanzaniaTotal Persons enrolled in HIV Care 18,687* 91,87571, ,487* Persons initiated on ART 13,275* 118,295 61,69644,404129,375*
Evaluation of Tuberculosis Drug Resistance among Nigerian HIV+ Patients in the Harvard PEPFAR/APIN Plus Program Using the Genotype MTBDRplus Test Lana.
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
Improving Patients Retention in Antiretroviral Treatment Programs: The experience of ARV Programs in Côte d’Ivoire Eugène MESSOU, MD, PhD CePReF- Aconda.
Differentiated Monitoring & Evaluation
MOVING FORWARD Enhanced ART Monitoring in Countries: Botswana
Peeramon Ningsanond MD. Bureau of AIDS TB STI, DDC, MOPH Thailand
Barriers and Facilitators of Retention in a Decentralized HIV Treatment Program in North Central Nigeria: A Qualitative Analysis Kolawole GO1, Dadem.
By Nour Elhouda Ata Alla Assistant Professor, Consultant Paediatrician
Cross-sectional assessment of patient outcomes using a systematic file review process: Results from 12,987 patient files Ambereen Jaffer, Gesine Meyer-Rath,
Utilizing research as an opportunity to strengthen
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
EVALUATION OF ANTIRETROVIRAL THERAPY FOLLOWED BY AN EDUCATIONAL INTERVENTION TO INCREASE APPROPRIATE USE IN ZIMBABWE.
Charles Gilks HIV Department, WHO
Presentation transcript:

HIV Care and Treatment: Benefits of Electronic Medical Records Phyllis Kanki 1, Seema Meloni 1,Beth Chaplin 1, Bolanle Banigbe 2, Prosper Okonkwo 2 1 Harvard School of Public Health, Boston, MA USA 2 AIDS Prevention Initiative Nigeria, Ltd./Gte., Abuja, Nigeria AIDS Turning the Tide Together

ART to 79,584 AIDS patients HIV care to 95,389 and ART to 61,891 Master Trainer Corps: Trainers treated 13,578 AIDS patients

Harvard PEPFAR Nigeria Through Bill & Melinda Gates Foundation funding, Harvard has been working with multiple hospitals and prevention programs in Nigeria since 2000 Started PEPFAR ART activities at 6 tertiary hospitals in 2004 and expanded to a total of 26 ART sites and 64 PMTCT sites Cumulative in Palliative Care Adults6,15118,51836,50459,05175,512113,567128,895 Pediatrics4491,1322,1673, Cumulative on ART Adults2,76012,16523,10838,05055,79372,90678,931 Pediatrics974851,2841,9513,2603,897

Organization of Electronic Data System Paper Records Daily, on-site data entry by (multiple) locally-hired & trained personnel Regular transfer to data managers’ computers for cleaning, merging, management and use. Physician views patient data in clinical rooms APIN Feedback to sites Harvard provides TA to APIN SI team

Electronic Medical Records System Pre- assessment Entry ARV naïve ARV experienced ART eligibl e ART ineligible Palliative Care Visit Lab Pharmacy ART eligibl e Discontinue ToxicityFailure VCT

PMTCT Program Databases/Forms Antenatal Care Lab Pharmacy DeliveryLab Exposed Infant Follow-up Pharmacy Lab If infant becomes HIV+, switched to pediatric HIV program *Some women enter PMTCT through VCT or adult program Antenatal Care Antenatal Care Antenatal Care Antenatal Care

CD4 Each green triangle indicates one pickup of antiretroviral medications. Orange triangles indicate a change in regimen. Log of Viral Load Laboratory Values Pharmacy Pickups

Identifying patients failing ART tested for HIV ‐ 1 drug resistance; subsequently switched to second line therapy

Patient Monitoring: Pharmacy Database Adherence Utility Assess adherence to treatment based on timeliness of drug pick-ups Use calculation of average percent adherence Setting up networks so that pharmacists can cross-check prescriptions

Site Assessment Indicators Continuity of care ART initiation CTX coverage TB screening coverage Lab data –% Charts missing values Toxicity –% patients with panic values –% patients with appropriate clinical response(s) CD4 and Viral Load –% patients with values at baseline, 3, 6, and 12 months –% patients with >50 cell/mL CD4 increase and/or suppressing viral load at 6 and 12 months Treatment failure –% patients in failure at 6 and 12 months –% patients with appropriate clinical response(s)

Electronic Record Systems Patient Monitoring –Treatment response –Adherence monitoring –Loss to Follow-Up –Toxicity monitoring Program Monitoring –Reports –Quality Assessment Drug usage and projections Program evaluations

Electronic Record Systems – Summary In clinics with large patient burdens – electronic record systems can optimize patient care. Data systems can promote patient care with automated utilities Program reporting and evaluations can be readily performed in real-time and is cost-efficient.

Acknowledgements This work was funded, in part, by the U.S. Department of Health and Human Services, Health Resources and Services Administration. P. Kanki (PI) S. Meloni E. Ekong B. Chaplin H. Rawizza J-L. Sankalé A. Dieng-Sarr G. Eisen D. Hamel N. Ulenga L. Dinic J. Hosseini C.Smith R. Murphy K. Scarsi K. Hurt B. Taiwo C.Achenbach P. Okonkwo T. Jolayemi B. Aluko S. Ochigbo R. Olaitan J. Samuels P. Akande T. Oyebode B. Akinyemi O. Eberendu C. O’Martins I. Adewole D. Olaleye J. Idoko S. Sagay O. Agbaji O. Idigbe D. Onwujekwe C. Okany R. Nkado W. Gashau H. Muktar J. Abah C. Chukwuka S. Akanmu F. Ogunsola All our colleagues at the APIN PEPFAR sites in Nigeria Most of all, our patients